- World rank, all time
- #31,925 of 42,892
- Rank in Spain
- #742 of 927
- Research works
- 137 ▲ 17% vs 2013–17
- Citations
- 1.8k 13.4 per fractional work
- Top-10% rate
- 7.8% record average 16.5%
- Open access
- 44% world 28%
What does Instituto de Salud Musculoesquelética specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.0× the share of its output that it takes of world research.
- MedicineField · 29.7 works4.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Health Professions 2.4×
- Immunology and Microbiology 1.8×
- Mathematics 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Economics, Econometrics and Finance 0.8×
- Chemistry 0.7×
- Biochemistry, Genetics and Molecular Biology 0.6×
- Nursing 0.5×
- Arts and Humanities 0.5×
- Business, Management and Accounting 0.3×
- Dentistry 0.2×
- Decision Sciences 0.2×
- Social Sciences 0.2×
- Computer Science 0.1×
- Engineering 0.1×
- Neuroscience 0.0×
- Psychology 0.0×
Who are the top researchers at Instituto de Salud Musculoesquelética?
Ranked on the composite score, Loreto Carmona, María Jesús García de Yébenes and Estíbaliz Loza lead among researchers whose main affiliation is Instituto de Salud Musculoesquelética.
- 1 Loreto Carmona Spain · #58,609 worldwide 271 citations · 82 works
- 2 María Jesús García de Yébenes Spain · #917,958 worldwide 11 citations · 19 works
- 3 Estíbaliz Loza Spain · #1,034,240 worldwide 50 citations · 46 works
- 4 Teresa Otón Spain · #1,061,974 worldwide 16 citations · 17 works
Which keywords describe research at Instituto de Salud Musculoesquelética?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Autoantibodies, Inflammation, Epidemiology, Rheumatoid Arthritis, Cytokines, Cardiovascular Risk, Biological Therapy and Disease-Modifying Antirheumatic Drugs.
- Training
- Prevention
- Disability
- Low Back Pain
- Rituximab
- Diagnosis
- Immunosuppressive Therapy
- Clinical Trials
- Public Health
- Fibromyalgia
- Chronic Pain
- Central Sensitization
- Macrophage Activation Syndrome
- Ankylosing Spondylitis
- Juvenile Idiopathic Arthritis
- Treatment
- Disease-Modifying Antirheumatic Drugs
- Biological Therapy
- Rheumatoid Arthritis
- Epidemiology
- Autoantibodies
- Inflammation
- Cytokines
- Cardiovascular Risk
- Joint Inflammation
- Psychological Factors
- Quality of Life
- Hemophagocytic Lymphohistiocytosis
- Spondyloarthritis
- Chronic Fatigue Syndrome
- Diagnostic Criteria
- Primary Care
- Antiphospholipid Syndrome
- Healthcare
- Systemic Lupus Erythematosus
- Musculoskeletal Disorders
- Global Burden
- Medical Education
- Measurement Properties
- Risk Factors
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Autoantibodies6▲ 63×5 topics
- Epidemiology6▲ 3.7×24 topics
- Inflammation5▲ 6.2×12 topics
- Rheumatoid Arthritis4▲ 98×3 topics
- Cytokines3▲ 31×2 topics
- Biological Therapy3▲ 152×2 topics
- Cardiovascular Risk3▲ 28×3 topics
- Disease-Modifying Antirheumatic Drugs3▲ 167×1 topic
- Joint Inflammation3▲ 167×1 topic
- Treatment3▲ 6.1×10 topics
- Psychological Factors3▲ 34×3 topics
- Juvenile Idiopathic Arthritis2▲ 128×2 topics
- Quality of Life2▲ 3.7×15 topics
- Ankylosing Spondylitis2▲ 184×1 topic
- Hemophagocytic Lymphohistiocytosis2▲ 221×1 topic
- Macrophage Activation Syndrome2▲ 221×1 topic
- Spondyloarthritis2▲ 184×1 topic
- Central Sensitization2▲ 72×2 topics
- Chronic Fatigue Syndrome2▲ 144×1 topic
- Chronic Pain2▲ 19×5 topics
- Diagnostic Criteria2▲ 19×2 topics
- Fibromyalgia2▲ 144×1 topic
- Primary Care2▲ 10×7 topics
- Public Health2▲ 2.7×9 topics
- Antiphospholipid Syndrome1▲ 74×1 topic
- Clinical Trials1▲ 5.3×6 topics
- Healthcare1▲ 3.3×10 topics
- Immunosuppressive Therapy1▲ 19×3 topics
- Systemic Lupus Erythematosus1▲ 66×1 topic
- Diagnosis1▲ 3.6×11 topics
- Musculoskeletal Disorders1▲ 33×2 topics
- Rituximab1▲ 23×4 topics
- Global Burden1▲ 5.8×3 topics
- Low Back Pain1▲ 19×2 topics
- Medical Education1▲ 12×4 topics
- Disability1▲ 26×1 topic
- Measurement Properties1▲ 37×1 topic
- Prevention1▲ 7.1×3 topics
- Risk Factors1▲ 2.5×5 topics
- Training1▲ 13×3 topics
Which research topics does Instituto de Salud Musculoesquelética publish most on?
By volume in 2022–2025: Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Autoimmune and Inflammatory Disorders Research and Fibromyalgia and Chronic Fatigue Syndrome Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Rheumatoid Arthritis Research and Therapies Rheumatology 3 works
- 2 Spondyloarthritis Studies and Treatments Rheumatology 2 works
- 3 Autoimmune and Inflammatory Disorders Research Hematology 2 works
- 4 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 2 works
- 5 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 6 Musculoskeletal pain and rehabilitation Pharmacology 1 works
- 7 Musculoskeletal Disorders and Rehabilitation Rehabilitation 1 works
- 8 Vasculitis and related conditions Pulmonary and Respiratory Medicine 1 works
- 9 Medical research and treatments Surgery 1 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto de Salud Musculoesquelética's research output changed?
Output in 2018–2022 was 17% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Madrid
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.